Search Page

1

Cite

Share

International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress.

Woodward DF, Jones RL, Narumiya S. Woodward DF, et al. Pharmacol Rev. 2011 Sep;63(3):471-538. doi: 10.1124/pr.110.003517. Epub 2011 Jul 13. Pharmacol Rev. 2011. PMID: 21752876 Review.

Cite

Share

2

Cite

Share

Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics.

Woodward DF, Wang JW, Poloso NJ. Woodward DF, et al. Pharmacol Rev. 2013 Jul 26;65(4):1135-47. doi: 10.1124/pr.112.007088. Print 2013. Pharmacol Rev. 2013. PMID: 23893067 Review.

Cite

Share

3

Cite

Share

Bimatoprost: a novel antiglaucoma agent.

Woodward DF, Phelps RL, Krauss AH, Weber A, Short B, Chen J, Liang Y, Wheeler LA. Woodward DF, et al. Cardiovasc Drug Rev. 2004 Summer;22(2):103-20. doi: 10.1111/j.1527-3466.2004.tb00134.x. Cardiovasc Drug Rev. 2004. PMID: 15179448 Review.

Cite

Share

4

Cite

Share

Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles.

Chen J, Senior J, Marshall K, Abbas F, Dinh H, Dinh T, Wheeler L, Woodward D. Chen J, et al. Br J Pharmacol. 2005 Feb;144(4):493-501. doi: 10.1038/sj.bjp.0706044. Br J Pharmacol. 2005. PMID: 15678094 Free PMC article.

Cite

Share

5

Cite

Share

The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products.

Woodward DF, Carling RW, Cornell CL, Fliri HG, Martos JL, Pettit SN, Liang Y, Wang JW. Woodward DF, et al. Pharmacol Ther. 2008 Oct;120(1):71-80. doi: 10.1016/j.pharmthera.2008.08.001. Epub 2008 Aug 6. Pharmacol Ther. 2008. PMID: 18700152 Review.

Cite

Share

6

Cite

Share

In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.

Woodward DF, Wang JW, Ni M, Bauer A, Martos JL, Carling RW, Poloso NJ. Woodward DF, et al. FASEB J. 2017 Jan;31(1):368-375. doi: 10.1096/fj.201600604R. Epub 2016 Oct 21. FASEB J. 2017. PMID: 27770021

Cite

Share

7

Cite

Share

Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.

Wang JW, Woodward DF, Martos JL, Cornell CL, Carling RW, Kingsley PJ, Marnett LJ. Wang JW, et al. Among authors: woodward df. FASEB J. 2016 Jan;30(1):394-404. doi: 10.1096/fj.15-275610. Epub 2015 Sep 29. FASEB J. 2016. PMID: 26420849

Cite

Share

8

Cite

Share

PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4).

Poloso NJ, Urquhart P, Nicolaou A, Wang J, Woodward DF. Poloso NJ, et al. Among authors: woodward df. Mol Immunol. 2013 Jul;54(3-4):284-95. doi: 10.1016/j.molimm.2012.12.010. Epub 2013 Jan 20. Mol Immunol. 2013. PMID: 23337716

Cite

Share

9

Cite

Share

Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow.

Wang JW, Woodward DF, Stamer WD. Wang JW, et al. Among authors: woodward df. Invest Ophthalmol Vis Sci. 2013 Jul 16;54(7):4782-90. doi: 10.1167/iovs.13-12363. Invest Ophthalmol Vis Sci. 2013. PMID: 23766471 Free PMC article.

Cite

Share

10

Cite

Share

Fixed-combination and emerging glaucoma therapies.

Woodward DF, Chen J. Woodward DF, et al. Expert Opin Emerg Drugs. 2007 May;12(2):313-27. doi: 10.1517/14728214.12.2.313. Expert Opin Emerg Drugs. 2007. PMID: 17604504 Review.

Cite

Share